PREDICT-PVI Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention

NCT02180373 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2021-10-05

No results posted yet for this study

Summary

The overall goal of this multicenter collaborative research study is to identify genetic, proteomic, and/or lipidic (lipidomic) biomarkers associated with the outcomes of lower extremity revascularization in patients with advanced peripheral artery disease (PAD).

Conditions

Sponsors & Collaborators

  • Vascular Cures

    lead OTHER

Principal Investigators

  • Michael S Conte, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2017-07-28
Completion
2017-07-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02180373 on ClinicalTrials.gov